title: Impact of transfer for primary percutaneous coronary intervention on survival and clinical outcomes (from the HORIZONS-AMI Trial).
authors.affiliation: Clinic of Internal Medicine II, University of Ulm, Germany. jochen.woehrle@uniklinik-ulm.de
authors.forename: Jochen
authors.initials: J
authors.lastname: Wöhrle
authors.forename: Martin
authors.initials: M
authors.lastname: Desaga
authors.forename: Chris
authors.initials: C
authors.lastname: Metzger
authors.forename: Kurt
authors.initials: K
authors.lastname: Huber
authors.forename: Harry
authors.initials: H
authors.lastname: Suryapranata
authors.forename: Victor
authors.initials: V
authors.lastname: Guetta
authors.forename: Giulio
authors.initials: G
authors.lastname: Guagliumi
authors.forename: Bernhard
authors.initials: B
authors.lastname: Witzenbichler
authors.forename: Helen
authors.initials: H
authors.lastname: Parise
authors.forename: Roxana
authors.initials: R
authors.lastname: Mehran
authors.forename: Gregg W
authors.initials: GW
authors.lastname: Stone
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects; D000925:Anticoagulants / Q000627:therapeutic use; D016009:Chi-Square Distribution; D017023:Coronary Angiography; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006629:Hirudins; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000401:mortality / Q000628:therapy*; D010360:Patient Transfer; D010446:Peptide Fragments / Q000627:therapeutic use; D016016:Proportional Hazards Models; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000627:therapeutic use; D018709:Statistics, Nonparametric; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D006493:Heparin; C074619:bivalirudin